Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Otsuka

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Otsuka's 2012 sales performance.

Otsuka

Allergan and Gedeon finally get antipsychotic green light

Allergan and Gedeon finally get antipsychotic green light Once-monthly examples include Otsuka/Lundbeck's Abilify Maintena (aripiprazole) and Johnson and Johnson's Invega Sustenna (paliperidone palmitate), while J&J is also developing a three-monthly paliperidone depot that ... It will reach the market shortly

Study shows Otsuka's TB drug works even in worst cases

Study shows Otsuka's TB drug works even in worst cases Otsuka's recently-approved tuberculosis therapy Deltyba is effective even in complicated infections caused by extensively drug-resistant (XDR) strains of the bacterium, says a new study.

Lundbeck and Otsuka's Rexulti set for August launch in US

Lundbeck and Otsuka's Rexulti set for August launch in US Follows the antipsychotic drug's FDA approval on Friday. A new antipsychotic drug developed by Lundbeck and Otsuka looks set to debut in the US in August after gaining FDA approval ... Otsuka will shortly report second quarter sales of the drug that will

Ten new medicines recommended in Europe

Ten new medicines recommended in Europe This is a copycat version of Bristol-Myers Squibb/Otsuka's blockbuster Abilify (aripiprazole), which made $5.5bn last year, but is now starting to succumb to generic erosion.

More waiting for Allergan and Gedeon Richter's antipsychotic

More waiting for Allergan and Gedeon Richter's antipsychotic Alkermes' once-monthly depot formulation of aripiprazole lauroxil and Otsuka and Lundbeck's brexpiprazole, according to Decision Resources.

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...